Curaleaf Seeks to Halt Aurora Cannabis Share Issuance Amid Hostile Takeover Bid

Key Facts

1Curaleaf filed an application with the Alberta Securities Commission to halt Aurora's at-the-market share issuance program.

2Curaleaf claims Aurora's share issuances diluted shareholders by 11% and increased the offer cost by over $11 million.

Amid escalating tensions in the cannabis sector, Curaleaf has taken legal action to secure its position in a complex acquisition battle. Curaleaf filed an application with the Alberta Securities Commission to halt Aurora Cannabis's at-the-market (ATM) share issuance program, labeling it an abusive defensive tactic. The company claims these issuances have diluted shareholders by 11%, effectively increasing the acquisition offer cost by more than $11 million.

The move follows allegations by Curaleaf that Aurora continued issuing shares despite being aware of takeover interest since June 2026. According to market data, CURLF stock closed at $9.58 on September 11, 2026, with a daily range between $9.47 and $9.95. Curaleaf argues that Aurora's actions are unjustifiable given its reported debt-free status and cash reserves of approximately C$149 million.

Traders are now watching for the Alberta Securities Commission's decision, which could dictate deal certainty and the trajectory of CURLF, which stood at $9.58 (close September 11, 2026). With no direct cannabis-sector catalysts in the immediate economic calendar, the legal developments between the two entities remain the primary driver for price action in the coming days.